Flat6Labs, Organon launch 2nd cycle of Women’s Health Accelerator Programme

Flat6Labs, MENA’s leading seed and early-stage venture capital firm, and Organon, a global healthcare company dedicated to improving women’s health, have announced the launch of the second cycle of the Women’s Health Accelerator Programme. 

Launched in Cairo in 2011, Flat6Labs has multiple offices across the region with ongoing plans to expand into other emerging markets. It has invested in more than 100 innovative and tech-driven startups, and manages a number of seed funds with a total AUM in excess of US$85 million. 

Organon, meanwhile, is a global healthcare company formed through a spinoff from Merck, known as MSD, outside of the United States and Canada, to focus on improving the health of women throughout their lives. 

The two companies have now announced the second cycle of the Women’s Health Accelerator Programme, which builds on the success of the inaugural cycle, and aims to empower digital health startups with solutions to enhance women’s health across the Middle East, North Africa, and Turkey (MENAT) region.

The second cycle will hone in on three main focus sectors critical to women’s health – family planning, fertility planning, and women’s wellness. The overarching objective of the accelerator programme is to address specific challenges faced by women in the region concerning their health, aiming to find sustainable and long-term solutions. 

The initiative aims to accelerate the growth of 15 startups, and engage with various stakeholders, ultimately graduating startups that are ready to launch and address current challenges in women’s health. Additionally, the programme will include virtual and on-ground community events such as info sessions, roadshows, pitchathons, and webinars to strengthen outreach, scouting, and selection efforts.